| Application no. and date | 06772653.9 (espacenet) (Federated) (European Patent Register), 20060608 | | Patent/reg. no. and date | DK/EP 1898904, 20091007 | | Publication date | 20080319 | | Priority no. and date | US 689719 P, 20050610, US 690309 P, 20050614 | | EP pub. no. and date |
EP 1898904 20080319 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | 137200 | | Inventor | JOSHI, Yatindra, 38 Walker Drive
Princeton, NJ 08540, US,
KOWALSKI, James, 3727 Symes Drive
Belle Mead, NJ 08502, US,
LAKSHMAN, Jay, Parthiban, 215 Vista Drive
Cedar Knolls, NJ 07927, US,
SERAJUDDIN, Abu, T. M., 172-11 35 Avenue
Flushing, Queens, NY 11358, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/40 (2006.01) , A61K 9/22 (2006.01) , A61K 9/24 (2006.01) | | Title | 1-[(3-Hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidin-2(S)-carbonitril-formulering med modificeret frigivelse | | Int. application no. | US2006022416 | | Int. publication no. | WO2006135723 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
